Next 10 |
Vir Biotechnology, Inc. (“Vir” or “the Company”, Nasdaq: VIR) today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors (the “Board”) at its upcoming annual meeting of stockholders on May 29, 2024 (the ...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the first quarter ended March 31, 2024, on May 2, 2024. The Company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on May 2, 2024. ...
2024-03-26 14:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-15 11:30:03 ET H.C. Wainwright analyst issues UNDERPERFORM recommendation for VIR on March 15, 2024 10:00AM ET. The previous analyst recommendation was Underperform. VIR was trading at $10.54 at issue of the analyst recommendation. The overall analyst consensus :...
2024-03-15 11:30:03 ET J.P. Morgan analyst issues BUY recommendation for VIR on March 15, 2024 10:00AM ET. The previous analyst recommendation was Buy. VIR was trading at $10.54 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current anal...
2024-03-13 11:07:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Since Bill Gates left his position with Microsoft (NASDAQ: MSFT ) he diversified his stock portfolio away from the tech giant. Instead, biotechnology has been is primary interes...
– Over 60 participants dosed in two additional cohorts; initial data expected in the second quarter – – Approximately 50% of participants have compensated cirrhosis – Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that its Phase 2 SOLSTICE clin...
2024-02-26 06:55:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors know that the world of biotech stocks is home to a great percentage of opportunities that can triple and quadruple their capital. It’s also fairly easy to identify such sto...
2024-02-23 10:00:17 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming UBS concedes it wasn't bullis...
2024-02-22 20:49:13 ET More on etc. Vir Biotechnology, Inc. (VIR) Q4 2023 Earnings Call Transcript Hooker Furnishings: Temporary Headwinds Haven't Created An Attractive Buying Level MP Materials Corp. (MP) Q4 2023 Earnings Call Transcript Crude oil edges high...
News, Short Squeeze, Breakout and More Instantly...
Vir Biotechnology Inc. Company Name:
VIR Stock Symbol:
NYSE Market:
Vir Biotechnology, Inc. (“Vir” or “the Company”, Nasdaq: VIR) today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors (the “Board”) at its upcoming annual meeting of stockholders on May 29, 2024 (the ...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the first quarter ended March 31, 2024, on May 2, 2024. The Company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on May 2, 2024. ...
2024-03-26 14:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...